1,525
Participants
Start Date
June 1, 2026
Primary Completion Date
June 1, 2030
Study Completion Date
June 1, 2032
LevoCept
Levonorgestrel-Releasing Intrauterine System
Columbia University Medical Center, New York
Magee-Womens Hospital, Center for Family Planning Research, Pittsburgh
Hospital of the University of Pennsylvania, Philadelphia
Clinical Research of Philadelphia, LLC, Philadelphia
Tidewater Physicians for Women, Norfolk
Eastern Virginia Medical, Norfolk
Soapstone Center for Clinical Research, Decatur
Emory University School of Medicine Gynecology/Obstetrics, Atlanta
Ohio State University, Columbus
The Ohio State University Ob/Gyn Research Office, Columbus
University of Cincinnati/Reproductive Medicine Research, Cincinnati
IU Health University Hospital, Indianapolis
Planned Parenthood North Central States, Minneapolis
Planned Parenthood of the St. Louis Region and Southwest Missouri, Manchester
Advances In Health, Houston
University Of Colorado Department of Obstetrics & Gyncology, Aurora
University of Utah Healthcare Health Sciences Center, Salt Lake City
Rex Garn Mabey Jr., MD, Las Vegas
Essential Access Health-Los Angeles, Los Angeles
WR-Medical Center for Clinical Research, San Diego
Women's Health Care Research, San Diego
Stanford University, Medical Center, Obstetrics and Gynecolocy, Stanford
Essential Access Health-Berkeley, Berkeley
University of California Davis Health System Department of Obstetrics and Gynecology, Sacramento
University of Hawaii, Honolulu
Oregon Health & Science University, Portland
Seattle Women's: Health, Research, Gynecology, Seattle
Collaborators (1)
PRA Health Sciences
INDUSTRY
Sebela Women's Health Inc.
INDUSTRY